Skip to main content
Canada drops US from drug-price benchmark
8/9/2019

Canada's Patented Medicine Prices Review Board will no longer make coverage decisions based on prices in the US or Switzerland and may consider cost-effectiveness in decisions to cover new drugs.

Full Story: